Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

enVVeno Medical (NVNO) Capital Expenditures (2018 - 2020)

Historic Capital Expenditures for enVVeno Medical (NVNO) over the last 3 years, with Q4 2020 value amounting to $27540.0.

  • enVVeno Medical's Capital Expenditures rose 11254.92% to $27540.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $217714.0, marking a year-over-year decrease of 4017.05%. This contributed to the annual value of $37000.0 for FY2024, which is 1212.12% up from last year.
  • enVVeno Medical's Capital Expenditures amounted to $27540.0 in Q4 2020, which was up 11254.92% from $5313.0 recorded in Q1 2020.
  • enVVeno Medical's 5-year Capital Expenditures high stood at $177230.0 for Q2 2019, and its period low was $1800.0 during Q1 2019.
  • For the 3-year period, enVVeno Medical's Capital Expenditures averaged around $57263.9, with its median value being $12957.0 (2019).
  • In the last 5 years, enVVeno Medical's Capital Expenditures surged by 21579.33% in 2019 and then surged by 11254.92% in 2020.
  • enVVeno Medical's Capital Expenditures (Quarter) stood at $4103.0 in 2018, then soared by 215.79% to $12957.0 in 2019, then surged by 112.55% to $27540.0 in 2020.
  • Its Capital Expenditures was $27540.0 in Q4 2020, compared to $5313.0 in Q1 2020 and $12957.0 in Q4 2019.